CAS RN: 86499-96-9
3-Bromo-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one
Product Availability
Choose a grade to view its available package options.
2 package records2 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20251227 |
5g / 25g / 100g / 500g |
Confirm by inquiry |
Shanghai, Shandong | | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260209 |
5g / 25g / 100g |
Confirm by inquiry |
Shanghai | 8-10 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 5g, 100g, 10g, 25g
- Available purity: >97%
- Inventory rows with stock: 4
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 86499-96-9
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 5g |
>97% |
5
In Stock
|
Shanghai |
Inquiry |
| 100g |
>97% |
4
In Stock
|
Beijing |
Inquiry |
| 10g |
>97% |
3
In Stock
|
Shenzhen |
Inquiry |
| 25g |
>97% |
1
In Stock
|
Beijing |
Inquiry |
86499-96-9 / 3-bromo-1,3,4,5-tetrahydro-1-benzazepin-2-one
Standard CAS: 86499-96-9
Multi CAS: Yes
Basic Information
CAS
86499-96-9
Multi CAS
Yes
Molecular Formula
BC10H10ORn
Molecular Weight
240.100000
Exact Mass
238.994580
InChI
InChI=1S/C10H10BrNO/c11-8-6-5-7-3-1-2-4-9(7)12-10(8)13/h1-4,8H,5-6H2,(H,12,13)
InChIKey
JMXPGCGROVEPID-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
13
Aromatic heavy atom count
6
Fraction Csp3
0.3
H-bond acceptors
1
H-bond donors
1
Molar refractivity
56.11
TPSA
29.1
LogP / Solubility
WLOGP
2.33
MLOGP
2.06
XLogP3
2.3
Consensus LogP
2.23
Log S (ESOL)
-3.14
Class (ESOL)
Poorly soluble
Log S (Ali)
-3.21
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-3.16
Class (SILICOS-IT)
Poorly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.53
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
2